Search for a command to run...
<h3>Background and Importance</h3> The European Society of Clinical Pharmacy define clinical pharmacy as <i>‘both a professional practice and a field of research’</i>.<sup>1</sup> The European Statements of Hospital Pharmacy state that <i>‘hospital pharmacists should actively engage in and publish research’</i>.<sup>2</sup> <h3>Aim and Objectives</h3> Evaluate national practice relating to research within hospital pharmacy. Outline barriers to pharmacist research. <h3>Material and Methods</h3> A national online survey was developed. This was distributed to hospital pharmacy managers between May and August 2025 inclusive, via central mailing lists and contacts of the research team. Survey questions addressed Staffing structures. Current levels of research conducted. The type of research being conducted. Barriers to conducting research. Responses results were analysed descriptively. <h3>Results</h3> Fifty-five (65%) hospitals responded. Key findings included: Only 8% of departments had a dedicated research pharmacist. Conference abstracts were produced by 63% of hospitals. In contrast, only 32% had published in peer–reviewed publications. Most institutions produce quantitative (66%), qualitative (61%), or mixed–methods (45%) research. Only 46% of participants agreed that engaging in research is an ‘expectation of pharmacists’. However, 62% of participants agreed that research is encouraged in training, should be a requirement for specialist validation and should be embedded into job descriptions. Dissemination of research would encourage others to conduct research according to 92% of participants. Barriers to increased engagement in research included protected time. workload pressures. insufficient mentorship. limited funding opportunities. Respondents emphasised the need for structural-level changes within the education of pharmacists should engagement in research activities become embedded within pharmacists’ roles. <h3>Conclusion and Relevance</h3> Low levels of engagement with, and the absence of a standardised approach to research was common, as were structural barriers to increased pharmacist engagement. Strategic investment, protected dedicated posts, and academic partnerships are required to strengthen research, in line with the European Statements of Hospital Pharmacy (2). <h3>References and/or Acknowledgements</h3> 1. Dreischulte T, van den Bemt B, Steurbaut S; European Society of Clinical Pharmacy. European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper. <i>Int J Clin Pharm.</i> 2022 Aug;<b>44</b>(4):837–842. doi: 10.1007/s11096-022-01422-7. Epub 2022 Jun 6. PMID: 35668277; PMCID: PMC9393137. 2. The European Statements of Hospital Pharmacy. <i>European Journal of Hospital Pharmacy</i> 2014;<b>21</b>:256–258. <h3>Conflict of Interest</h3> Corporate sponsored research or other substantive relationships: No conflicts relevant to this abstract.